162 related articles for article (PubMed ID: 20702618)
1. Ultrastructural analysis of ICP34.5- herpes simplex virus 1 replication in mouse brain cells in vivo.
Mehta H; Muller J; Markovitz NS
J Virol; 2010 Nov; 84(21):10982-90. PubMed ID: 20702618
[TBL] [Abstract][Full Text] [Related]
2. Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like Cells.
Peters C; Paget M; Tshilenge KT; Saha D; Antoszczyk S; Baars A; Frost T; Martuza RL; Wakimoto H; Rabkin SD
J Virol; 2018 Aug; 92(15):. PubMed ID: 29793956
[TBL] [Abstract][Full Text] [Related]
3. Effect of γ34.5 deletions on oncolytic herpes simplex virus activity in brain tumors.
Kanai R; Zaupa C; Sgubin D; Antoszczyk SJ; Martuza RL; Wakimoto H; Rabkin SD
J Virol; 2012 Apr; 86(8):4420-31. PubMed ID: 22345479
[TBL] [Abstract][Full Text] [Related]
4. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.
Liu BL; Robinson M; Han ZQ; Branston RH; English C; Reay P; McGrath Y; Thomas SK; Thornton M; Bullock P; Love CA; Coffin RS
Gene Ther; 2003 Feb; 10(4):292-303. PubMed ID: 12595888
[TBL] [Abstract][Full Text] [Related]
5. Role of Herpes Simplex Virus 1 γ34.5 in the Regulation of IRF3 Signaling.
Manivanh R; Mehrbach J; Knipe DM; Leib DA
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904192
[TBL] [Abstract][Full Text] [Related]
6. Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2.
Korom M; Davis KL; Morrison LA
J Virol; 2014 Oct; 88(19):11284-96. PubMed ID: 25031346
[TBL] [Abstract][Full Text] [Related]
7. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation.
Perng GC; Thompson RL; Sawtell NM; Taylor WE; Slanina SM; Ghiasi H; Kaiwar R; Nesburn AB; Wechsler SL
J Virol; 1995 May; 69(5):3033-41. PubMed ID: 7707530
[TBL] [Abstract][Full Text] [Related]
8. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures.
Bolovan CA; Sawtell NM; Thompson RL
J Virol; 1994 Jan; 68(1):48-55. PubMed ID: 8254758
[TBL] [Abstract][Full Text] [Related]
9. Neurovirulent factor ICP34.5 uniquely expressed in the herpes simplex virus type 1 Delta gamma 1 34.5 mutant 1716.
Holman HA; MacLean AR
J Neurovirol; 2008 Jan; 14(1):28-40. PubMed ID: 18300073
[TBL] [Abstract][Full Text] [Related]
10. A neuroattenuated ICP34.5-deficient herpes simplex virus type 1 replicates in ependymal cells of the murine central nervous system.
Kesari S; Lasner TM; Balsara KR; Randazzo BP; Lee VM; Trojanowski JQ; Fraser NW
J Gen Virol; 1998 Mar; 79 ( Pt 3)():525-36. PubMed ID: 9519831
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and Efficacy of a Novel GADD34-expressing Oncolytic HSV-1 for the Treatment of Experimental Glioblastoma.
Nakashima H; Nguyen T; Kasai K; Passaro C; Ito H; Goins WF; Shaikh I; Erdelyi R; Nishihara R; Nakano I; Reardon DA; Anderson AC; Kuchroo V; Chiocca EA
Clin Cancer Res; 2018 Jun; 24(11):2574-2584. PubMed ID: 29511029
[No Abstract] [Full Text] [Related]
12. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2.
Brown SM; Harland J; MacLean AR; Podlech J; Clements JB
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2367-77. PubMed ID: 8077935
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus 2 ICP34.5 confers neurovirulence by regulating the type I interferon response.
Davis KL; Korom M; Morrison LA
Virology; 2014 Nov; 468-470():330-339. PubMed ID: 25238641
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic herpes virus with defective ICP6 specifically replicates in quiescent cells with homozygous genetic mutations in p16.
Aghi M; Visted T; Depinho RA; Chiocca EA
Oncogene; 2008 Jul; 27(30):4249-54. PubMed ID: 18345032
[TBL] [Abstract][Full Text] [Related]
15. [Oncolytic virotherapy using replication-competent herpes simplex viruses].
Nishiyama Y; Goshima F
Uirusu; 2007 Jun; 57(1):57-65. PubMed ID: 18040155
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus type 1 mutants containing the KOS strain ICP34.5 gene in place of the McKrae ICP34.5 gene have McKrae-like spontaneous reactivation but non-McKrae-like virulence.
Perng GC; Mott KR; Osorio N; Yukht A; Salina S; Nguyen QH; Nesburn AB; Wechsler SL
J Gen Virol; 2002 Dec; 83(Pt 12):2933-2942. PubMed ID: 12466469
[TBL] [Abstract][Full Text] [Related]
17. Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potential.
Mao H; Rosenthal KS
J Virol; 2003 Mar; 77(6):3409-17. PubMed ID: 12610116
[TBL] [Abstract][Full Text] [Related]
18. Herpes Simplex Virus 1 ICP34.5 Alters Mitochondrial Dynamics in Neurons.
Manivanh R; Mehrbach J; Charron AJ; Grassetti A; Cerón S; Taylor SA; Cabrera JR; Gerber S; Leib DA
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376626
[TBL] [Abstract][Full Text] [Related]
19. Oncolytic viruses derived from the gamma34.5-deleted herpes simplex virus recombinant R3616 encode a truncated UL3 protein.
Dambach MJ; Trecki J; Martin N; Markovitz NS
Mol Ther; 2006 May; 13(5):891-8. PubMed ID: 16574492
[TBL] [Abstract][Full Text] [Related]
20. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.
Kambara H; Okano H; Chiocca EA; Saeki Y
Cancer Res; 2005 Apr; 65(7):2832-9. PubMed ID: 15805284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
